Pharmafit Provence
CRISTAL Children's suppositories 10Sachet

Coopération Pharmaceutique Française

CRISTAL Children's suppositories 10Sachet

CIP / EAN code: 3400933195878

Product information from VIDAL.

Read the product information

Product information

Find indications, dosage and precautions in the sections below.

Automatic English translation of the French VIDAL document. Original numerical values and units are retained, including decimal commas.

VIDAL
Medicines
SmPC of 30/04/2014

CRISTAL CHILDREN, suppository


Forms and presentations

Suppository.


Composition

Glycerol ......................................................................................................................................................................1,290 g

For a suppository of 2,15 g.


Excipients:

Gelatin, purified water.



Indications

  • Symptomatic treatment of low constipation, particularly due to rectal dyschezia.
  • Preparation for endoscopic examinations of the rectum.


Dosage and administration

Children aged 2 to 6 years: 1 suppository 5 at 30 minutes before the time chosen for evacuation.

Children over 6 years: 1 suppository 5 at 30 minutes before the time chosen for evacuation, to be repeated if necessary within the half-hour or hour that follows in case of stubborn constipation.

The treatment of constipation should not, on average, exceed 10 days.



Contraindications

History of hypersensitivity to glycerol or to any of the other constituents mentioned in the section Composition.



Warnings and precautions

Warnings

Prolonged use is not recommended.

In children, the prescription of laxatives by the rectal route should be exceptional: it must take into account the risk of impairing the normal functioning of the evacuation reflex.

Precautions for use

It is preferable not to use this medicine in cases of colonic or rectal diseases.



Interactions

The data available to date do not suggest the existence of clinically significant interactions.



Adverse effects

Prolonged use may give rise to sensations of anal burning and, exceptionally, congestive proctitis.

Reporting of suspected adverse reactions

Reporting suspected adverse effects after authorisation of the medicinal product is important. It allows continuous monitoring of the benefit/risk balance of the medicinal product. Health professionals should report any suspected adverse effect via the national reporting system: National Agency for the Safety of Medicines and Health Products (ANSM) and the network of Regional Pharmacovigilance Centres. Website: www.ansm.sante.fr.



Overdose

No cases of overdose have been reported. However, in case of prolonged use, increased risk of proctitis and diarrhoea.



Pharmacodynamics

Pharmacotherapeutic class: OTHER LAXATIVES, ATC code A06AX01

(A: Alimentary tract and metabolism)

Rectal route.

Glycerin suppositories cause rapid evacuation of the rectosigmoid by triggering the defecation reflex. Defecation occurs within 5 to 30 minutes after administration.

Glycerol stimulates peristaltic movements and decreases water reabsorption through its osmotic and hygroscopic properties. It also has a local irritant effect that contributes to the reflex defecation.



Shelf life

3 years.



Special storage precautions

To be stored at a temperature not exceeding 25°C.



SPECIAL PRECAUTIONS FOR DISPOSAL AND OTHER HANDLING

No special requirements.



Prescription, supply and reimbursement

Marketing authorisation (AMM)
CIP 3400933195878 (10 sachets).
Not reimbursed by Social Security.

Coopération Pharmaceutique Française
PLACE LUCIEN AUVERT
77020 MELUN CEDEX
Tel: 01 64 87 20 00 https://www.cooper.fr/

Source: VIDAL · Updated on 10/11/2026. This information does not replace advice from a healthcare professional.